VBI Vaccines Inc (VBV):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:VBI Vaccines Inc (VBV) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8010
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:44
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
VBI Vaccines Inc (VBI), a subsidiary of SciVac Therapeutics Inc is a biopharmaceutical company that discovers and develops novel vaccines for the treatment of immuno-oncology and infectious diseases. The company’s pipeline vaccine candidates include cytomegalovirus; glioblastoma multiforme and zika virus. It utilizes technologies such as eVLP platform, and thermostable platform to develop the vaccine candidates. VBI offers Sci-B-Vac, a hepatitis B vaccine which consists of surface antigens of hepatitis B virus and is free of any next-generation adjuvant. The company operates through its research facilities located in Ottawa, Canada; and a manufacturing facility in Rehovot, Israel. VBI is headquartered in Cambridge, Massachusetts, the US.

VBI Vaccines Inc (VBV) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
VBI Vaccines Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
VBI Vaccines Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
VBI Vaccines Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
VBI Vaccines Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
VBI Vaccines Inc, Medical Devices Deals, 2012 to YTD 2018 10
VBI Vaccines Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
VBI Vaccines Inc, Pharmaceuticals & Healthcare, Deal Details 13
Venture Financing 13
Variation Biotech Raises US$1.5 Million In Venture Financing 13
Variation Biotech Raised US$1.4 Million In Venture Financing 14
Variation Biotech Raises US$0.25 Million In Venture Financing 15
Variation Biotech Raises US$0.8 Million In Venture Financing 16
Variation Biotech Raises Additional US$1.2 Million In Venture Financing 17
VBI Vaccines Inc – Key Employees 19
VBI Vaccines Inc – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 21
Financial Announcements 21
Jul 26, 2018: VBI Vaccines Announces Second Quarter 2018 Financial Results and Provides Corporate Update 21
May 01, 2018: VBI Vaccines Reports First Quarter 2018 Financial Results 23
Corporate Communications 25
Sep 26, 2018: VBI Vaccines announces formation of new scientific and clinical advisory boards 25
Aug 15, 2018: VBI Vaccines appoints Christopher McNulty as chief financial officer and head of business development 27
Mar 12, 2018: VBI Vaccines Announces Voluntary Delisting from the Toronto Stock Exchange 28
Jan 26, 2018: VBI Vaccines Announces Changes to its Board of Directors 29
Nov 02, 2017: VBI Vaccines Strengthens Board of Directors with Appointment of Ran Nussbaum 30
Government and Public Interest 31
May 31, 2017: Researchers Explore the Possible Link between CMV Infection, Obesity, and Metabolic Syndrome 31
Product News 32
11/10/2017: VBI Vaccines to Present New Preclinical Data for its GBM Immunotherapy, VBI-1901, at SITC 2017 32
04/17/2018: VBI Vaccines Announces Positive DSMB Review in Phase 1/2a Study of VBI-1901 in Recurrent Glioblastoma (GBM) Patients 33
04/05/2017: VBI Vaccines to Present Update on VBI-1901 at the World Vaccine Congress 34
02/07/2017: VBI Vaccines Receives Positive EMA Scientific Advice Regarding Sci-B-Vac Phase III Clinical Study 35
01/17/2018: VBI Vaccines Announces Dosing of First GBM Patient in Phase 1/2a Clinical Study of VBI-1901 36
Product Approvals 37
Aug 15, 2017: VBI Vaccines Announces FDA Acceptance of Investigational New Drug Application for VBI-1901 to Treat Glioblastoma Multiforme 37
Clinical Trials 38
Oct 11, 2017: VBI Vaccines to Present Phase 1 CMV vaccine data at The World Vaccine Congress Europe 2017 in Barcelona 38
Oct 11, 2017: VBI Vaccines to Present preclinical Zika vaccine data at The World Vaccine Congress Europe 2017 in Barcelona 39
Aug 28, 2017: VBI Vaccines to Present New Preclinical Data for its GBM Immunotherapy, VBI-1901, at The Immuno-Oncology Summit 40
Jul 27, 2017: VBI Vaccines Announces Positive Interim Data from Phase 1 Study of Preventative CMV Vaccine 41
May 02, 2017: VBI Vaccines Provides Update on its Congenital CMV Phase I Clinical Study 42
Feb 22, 2017: VBI Vaccines Receives Positive Response from Health Canada’s Initial Evaluation of the Proposed Sci-B-Vac Phase III Clinical Program 43
Appendix 44
Methodology 44
About GlobalData 44
Contact Us 44
Disclaimer 44

List of Tables
VBI Vaccines Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
VBI Vaccines Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
VBI Vaccines Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
VBI Vaccines Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
VBI Vaccines Inc, Deals By Therapy Area, 2012 to YTD 2018 9
VBI Vaccines Inc, Medical Devices Deals, 2012 to YTD 2018 10
VBI Vaccines Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Variation Biotech Raises US$1.5 Million In Venture Financing 13
Variation Biotech Raised US$1.4 Million In Venture Financing 14
Variation Biotech Raises US$0.25 Million In Venture Financing 15
Variation Biotech Raises US$0.8 Million In Venture Financing 16
Variation Biotech Raises Additional US$1.2 Million In Venture Financing 17
VBI Vaccines Inc, Key Competitors 18
VBI Vaccines Inc, Key Employees 19
VBI Vaccines Inc, Other Locations 20
VBI Vaccines Inc, Subsidiaries 20

List of Figures
VBI Vaccines Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
VBI Vaccines Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
VBI Vaccines Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
VBI Vaccines Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
VBI Vaccines Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
VBI Vaccines Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
VBI Vaccines Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
VBI Vaccines Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
VBI Vaccines Inc, Medical Devices Deals, 2012 to YTD 2018 10

★海外企業調査レポート[VBI Vaccines Inc (VBV):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • China Oilfield Services Ltd (2883):企業の財務・戦略的SWOT分析
    China Oilfield Services Ltd (2883) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • RussNeft Oil Co (RNFT):石油・ガス:M&Aディール及び事業提携情報
    Summary RussNeft Oil Company (RussNeft) is an oil and gas company that produces, refines and distributes crude oil, gas and petroleum products. The company operates through its business divisions such as geologic exploration and reserves, production, marketing, research center, transport and gas pro …
  • iPass Inc. (IPAS):企業の財務・戦略的SWOT分析
    iPass Inc. (IPAS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Fingrid Oyj:発電所・企業SWOT分析
    Fingrid Oyj - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (execut …
  • mBank Private Banking:企業の戦略・SWOT・財務情報
    mBank Private Banking - Strategy, SWOT and Corporate Finance Report Summary mBank Private Banking - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Coloplast AS (COLO B):企業の財務・戦略的SWOT分析
    Coloplast AS (COLO B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Canadian Utilities Limited
    Canadian Utilities Limited - Strategy, SWOT and Corporate Finance Report Summary Canadian Utilities Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Clayton General Inc:企業の戦略的SWOT分析
    Clayton General Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Phibro Animal Health Corp (PAHC):企業の財務・戦略的SWOT分析
    Phibro Animal Health Corp (PAHC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Publix Super Markets Inc (PUSH):企業の財務・戦略的SWOT分析
    Publix Super Markets Inc (PUSH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • PetroNeft Resources plc (P8ET):石油・ガス:M&Aディール及び事業提携情報
    Summary PetroNeft Resources Plc (PetroNeft) is an upstream oil and gas company. It carries out exploration, development and production of oil and natural gas. The company mainly focuses on oil rich Western Siberia zone in Russia. PetroNeft’s asset base comprises of 50% interest each in License 61 an …
  • EVA Airways Corporation:戦略・SWOT・企業財務分析
    EVA Airways Corporation - Strategy, SWOT and Corporate Finance Report Summary EVA Airways Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • CONSOL Energy Inc.:企業の戦略・SWOT・財務情報
    CONSOL Energy Inc. - Strategy, SWOT and Corporate Finance Report Summary CONSOL Energy Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • F. Hoffmann-La Roche Ltd (ROG):企業の財務・戦略的SWOT分析
    F. Hoffmann-La Roche Ltd (ROG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Torii Pharmaceutical Co Ltd (4551):製薬・医療:M&Aディール及び事業提携情報
    Summary Torii Pharmaceutical Co Ltd (Torii) a subsidiary of Japan Tobacco Inc is a healthcare product provider that manufactures and markets products such as antebate ointment, antebate cream and urinorm used for the treatment of hyperuricemia and gout. The company offers products for the treatment …
  • Avivagen Inc (VIV):企業の財務・戦略的SWOT分析
    Summary Avivagen Inc (Avivagen), is a biotechnology company that provides drug development and animal healthcare products. It offers OxC-beta an active ingredient used to support the innate immune system and a healthy inflammatory condition of living beings. Avivagen's oxidized carotenoids promote a …
  • Fluidra, S.A. (FDR):企業の財務・戦略的SWOT分析
    Fluidra, S.A. (FDR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Suncor Energy Inc.:企業の戦略・SWOT・財務情報
    Suncor Energy Inc. - Strategy, SWOT and Corporate Finance Report Summary Suncor Energy Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Promius Pharma LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Promius Pharma LLC (Promius Pharma), a subsidiary of Dr. Reddy's Laboratories Ltd, is a designer of personal and practical health care solutions that provides dermatology and neurology products. The company provides dermatology and neurology products. Its products include clocortolone pivala …
  • PTT Exploration and Production Public Co Ltd (PTTEP):企業の財務・戦略的SWOT分析
    PTT Exploration and Production Public Co Ltd (PTTEP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s k …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆